Australian Yasmin Case Sets New Yardstick For Damages Claims; Stings Lupin Arm

The Australian Federal Court appears to have dealt a stinging blow to Lupin’s subsidiary there in a case pertaining to the infringement of the patent on Bayer’s oral contraceptive Yasmin. The case, some legal eagles say, gives a rare indication of how Australian courts may approach damages claims against infringing generic copies.